Literature DB >> 26572153

miR-411 contributes the cell proliferation of lung cancer by targeting FOXO1.

Zhiju Zhao1,2, Limei Qin3, Shu Li4.   

Abstract

Lung cancer is the leading cause of cancer deaths worldwide; the study of microRNAs gives new hope for lung cancer treatment. miR-411 has been demonstrated to be an independent prognostic factor for lung adenocarcinoma, but the role and regulatory mechanism are largely unknown. In the present study, we found miR-411 was overexpressed in the lung cancer cells; overexpression of miR-411 promoted anchorage-dependent and anchorage-independent growths of lung cancer, while miR-411 knockdown reduced this effect. Further study showed forkhead box O1 (FOXO1) was a target of miR-411. Overexpression of miR-411 suppressed the expression of FOXO1; the effect of suppression was abrogated when the mutation occurred in the 3'UTR of FOXO1. Knockdown of FOXO1 in cells which miR-411 was inhibited recapitulated the phenotype of miR-411 overexpression. Taken together, our study revealed miR-411 promoted cell proliferation of lung cancer by targeting tumor suppressor gene FOXO1 and miR-411 might be a potential target for lung cancer therapy.

Entities:  

Keywords:  Cell proliferation; FOXO1; Lung cancer; miR-411

Mesh:

Substances:

Year:  2015        PMID: 26572153     DOI: 10.1007/s13277-015-4425-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  38 in total

Review 1.  Akt, FoxO and regulation of apoptosis.

Authors:  Xinbo Zhang; Naimei Tang; Timothy J Hadden; Arun K Rishi
Journal:  Biochim Biophys Acta       Date:  2011-03-31

2.  PAX3-FOXO1 induces cannabinoid receptor 1 to enhance cell invasion and metastasis.

Authors:  Amy D Marshall; Irina Lagutina; Gerard C Grosveld
Journal:  Cancer Res       Date:  2011-10-28       Impact factor: 12.701

3.  Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation.

Authors:  Haojie Huang; Kevin M Regan; Fang Wang; Diping Wang; David I Smith; Jan M A van Deursen; Donald J Tindall
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-24       Impact factor: 11.205

4.  Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas.

Authors:  Amy L McDoniels-Silvers; Caramella F Nimri; Gary D Stoner; Ronald A Lubet; Ming You
Journal:  Clin Cancer Res       Date:  2002-04       Impact factor: 12.531

5.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

Authors:  Nozomu Yanaihara; Natasha Caplen; Elise Bowman; Masahiro Seike; Kensuke Kumamoto; Ming Yi; Robert M Stephens; Aikou Okamoto; Jun Yokota; Tadao Tanaka; George Adrian Calin; Chang-Gong Liu; Carlo M Croce; Curtis C Harris
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

6.  miR-106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma.

Authors:  Gang Shen; Hongyun Jia; Qiang Tai; Yanhao Li; Deji Chen
Journal:  Carcinogenesis       Date:  2012-10-20       Impact factor: 4.944

7.  A MicroRNA cluster at 14q32 drives aggressive lung adenocarcinoma.

Authors:  Ernest Nadal; Jinjie Zhong; Jules Lin; Rishindra M Reddy; Nithya Ramnath; Mark B Orringer; Andrew C Chang; David G Beer; Guoan Chen
Journal:  Clin Cancer Res       Date:  2014-05-15       Impact factor: 12.531

8.  Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers.

Authors:  Eleni van Schooneveld; Maartje Ca Wouters; Ilse Van der Auwera; Dieter J Peeters; Hans Wildiers; Peter A Van Dam; Ignace Vergote; Peter B Vermeulen; Luc Y Dirix; Steven J Van Laere
Journal:  Breast Cancer Res       Date:  2012-02-21       Impact factor: 6.466

9.  Role of microRNA221 in regulating normal mammary epithelial hierarchy and breast cancer stem-like cells.

Authors:  Jia Ke; Zhiju Zhao; Su-Hyung Hong; Shoumin Bai; Zhen He; Fayaz Malik; Jiahui Xu; Lei Zhou; Weilong Chen; Rachel Martin-Trevino; Xiaojian Wu; Ping Lan; Yongju Yi; Christophe Ginestier; Ingrid Ibarra; Li Shang; Sean McDermott; Tahra Luther; Shawn G Clouthier; Max S Wicha; Suling Liu
Journal:  Oncotarget       Date:  2015-02-28

Review 10.  The potential clinical applications and prospects of microRNAs in lung cancer.

Authors:  Ying Gao; Fei Gao; Jin-Lu Ma; Wen-Ze Sun; Li-Ping Song
Journal:  Onco Targets Ther       Date:  2014-06-04       Impact factor: 4.147

View more
  20 in total

1.  High protein/fish oil diet prevents hepatic steatosis in NONcNZO10 mice; association with diet/genetics-regulated micro-RNAs.

Authors:  Nikhil Adi; Jennipher Adi; Roberta Marques Lassance-Soares; Paul Kurlansky; Hong Yu; Keith A Webster
Journal:  J Diabetes Metab       Date:  2016-06-16

Review 2.  Prognostic role of 14q32.31 miRNA cluster in various carcinomas: a systematic review and meta-analysis.

Authors:  Padacherri Vethil Jishnu; Pradyumna Jayaram; Vaibhav Shukla; Vinay Koshy Varghese; Deeksha Pandey; Krishna Sharan; Sanjiban Chakrabarty; Kapaettu Satyamoorthy; Shama Prasada Kabekkodu
Journal:  Clin Exp Metastasis       Date:  2019-12-07       Impact factor: 5.150

Review 3.  FOXO transcription factors in cancer development and therapy.

Authors:  Alexandra Coomans de Brachène; Jean-Baptiste Demoulin
Journal:  Cell Mol Life Sci       Date:  2015-12-19       Impact factor: 9.261

4.  Hyper-Editing of Cell-Cycle Regulatory and Tumor Suppressor RNA Promotes Malignant Progenitor Propagation.

Authors:  Qingfei Jiang; Jane Isquith; Maria Anna Zipeto; Raymond H Diep; Jessica Pham; Nathan Delos Santos; Eduardo Reynoso; Julisia Chau; Heather Leu; Elisa Lazzari; Etienne Melese; Wenxue Ma; Rongxin Fang; Mark Minden; Sheldon Morris; Bing Ren; Gabriel Pineda; Frida Holm; Catriona Jamieson
Journal:  Cancer Cell       Date:  2019-01-03       Impact factor: 31.743

5.  MicroRNA-411 promoted the osteosarcoma progression by suppressing MTSS1 expression.

Authors:  Ning Xu; Weiliang Yang; Yang Liu; Feng Yan; Zhange Yu
Journal:  Environ Sci Pollut Res Int       Date:  2018-02-16       Impact factor: 4.223

6.  miR-15a and miR-24-1 as putative prognostic microRNA signatures for pediatric pilocytic astrocytomas and ependymomas.

Authors:  M Braoudaki; G I Lambrou; K Giannikou; S A Papadodima; A Lykoudi; K Stefanaki; G Sfakianos; A Kolialexi; F Tzortzatou-Stathopoulou; M Tzetis; S Kitsiou-Tzeli; E Kanavakis
Journal:  Tumour Biol       Date:  2016-01-26

7.  Upregulation of miR‑598 promotes cell proliferation and cell cycle progression in human colorectal carcinoma by suppressing INPP5E expression.

Authors:  Kun-Ping Li; Yong-Ping Fang; Jin-Qi Liao; Jin-Dong Duan; Li-Guang Feng; Xiao-Zai Luo; Zhi-Jian Liang
Journal:  Mol Med Rep       Date:  2017-12-06       Impact factor: 2.952

Review 8.  FOXO Signaling Pathways as Therapeutic Targets in Cancer.

Authors:  Mohd Farhan; Haitao Wang; Uma Gaur; Peter J Little; Jiangping Xu; Wenhua Zheng
Journal:  Int J Biol Sci       Date:  2017-07-06       Impact factor: 6.580

9.  Transcriptomic profiling in human mesangial cells using patient-derived lupus autoantibodies identified miR-10a as a potential regulator of IL8.

Authors:  Pattarin Tangtanatakul; Boonyakiat Thammasate; Alain Jacquet; Rangsima Reantragoon; Trairak Pisitkun; Yingyos Avihingsanon; Asada Leelahavanichkul; Nattiya Hirankarn
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379

10.  Up-regulated microRNA-411 or declined RIPK1 inhibits proliferation and promotes apoptosis of synoviocytes in rheumatoid arthritis mice via decreased NF-κB pathway.

Authors:  Yijiang Huang; Kaizhe Chen; Huachen Yu; Daosen Chen; Lianfu Deng; Yu Zhang; Xinghe Xue; Xiaoyun Pan
Journal:  Cell Cycle       Date:  2020-03-01       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.